1. Exposure to common cold could provide immunity to Covid-19  Telegraph.co.uk
  2. Coronavirus: could it be burning out after 20% of a population is infected?  The Conversation UK
  3. A race to determine what drives COVID-19 severity  Nature.com
  4. Was coronavirus in Europe as early as March 2019?  The Independent
  5. Coronavirus: the antibody drugs few people have been discussing – until now  The Conversation UK
  6. View Full coverage on Google News
T-cells not antibodies may be the key to fighting off the virus, study showsT-cells not antibodies may be the key to fighting off the virus, study shows

Exposure to common cold could provide immunity to Covid-19

There is speculation about whether a population can achieve some sort of immunity to the virus with as little as 20% infected.There is speculation about whether a population can achieve some sort of immunity to the virus with as little as 20% infected.

Coronavirus: could it be burning out after 20% of a population is infected?

Coronavirus: could it be burning out after 20% of a population is infected?

Efforts are ongoing to find which human or viral factors underpin whether a person with COVID-19 will develop severe symptoms. Clinical evidence linked to two viral lineages now provides key insights into this enigma. Clinical evidence reveals how host factors affect coronavirus infection.Clinical evidence reveals how host factors affect coronavirus infection.

A race to determine what drives COVID-19 severity

Samples of wastewater in Barcelona have shown traces of coronavirus from as early as March 2019, but can we trust the results? Claire Crossan explains

Was coronavirus in Europe as early as March 2019? | The Independent

Vaccines and antivirals aren't the only game in town.Vaccines and antivirals aren't the only game in town.

Coronavirus: the antibody drugs few people have been discussing – until now

Coronavirus: the antibody drugs few people have been discussing – until now

Antiviral drug screen of kinase inhibitors, which was done by researchers from the University of California and Cedars-Sinai Medical Center, identified cellular signaling pathways critical for SARS-CoV-2 replication and revealed an important mechanism of host-pathogen interaction vital for further drug research. Their results are available on the bioRxiv* preprint server.Antiviral drug screen of kinase inhibitors, which was done by researchers from the University of California and Cedars-Sinai Medical Center, identified cellular signaling pathways critical for SARS-CoV-2 replication and revealed an important mechanism of host-pathogen interaction vital for further drug research. Their results are available on the bioRxiv* preprint server.

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Cells hijacked by SARS-CoV-2, a novel coronavirus that causes the COVID-19 disease, grow arm-like extensions, or filopodia, which may explain rapid viral spread throughout the body.Cells hijacked by SARS-CoV-2, a novel coronavirus that causes the COVID-19 disease, grow arm-like extensions, or filopodia, which may explain rapid viral spread throughout the body.

SARS-CoV-2 Coronavirus Produces Long Tentacles in Infected Cells | Medicine | Sci-News.com

UCSF scientists assembled an international research team that has figured out how SARS-CoV-2, the virus that causes COVID-19, hijacks proteins in host cells that serve as master regulators of key cellular processes.UCSF scientists assembled an international research team that has figured out how SARS-CoV-2, the virus that causes COVID-19, hijacks proteins in host cells that serve as master regulators of key cellular processes.

COVID-19 Relies on Cell’s ‘Master Regulators’ for Survival | UC San Francisco

Research explores the interaction between airway and immune cells to determine why some people are at greater risk than others of severe COVID-19.Research explores the interaction between airway and immune cells to determine why some people are at greater risk than others of severe COVID-19.

Why are some people at greater risk of severe COVID-19?

As experts are investigating antibodies as a treatment for Covid-19, research reveals insights into antibodies to the coronavirus that caused SARS years ago. As experts are investigating antibodies as a treatment for Covid-19, research reveals insights into antibodies to the coronavirus that caused SARS years ago.

Could antibodies from SARS help fight Covid-19? | Health24

Six months into the new coronavirus pandemic, researchers have raced to uncover crucial information about SARS-CoV-2. But much is still unknown.

Here's what we've learned in six months of COVID-19 | Science News

How exactly does the antiviral drug remdesivir counter SARS-CoV-2 – the coronavirus strain responsible for COVID-19? And how well?How exactly does the antiviral drug remdesivir counter SARS-CoV-2 – the coronavirus strain responsible for COVID-19? And how well?

How remdesivir works, and why it's not the ultimate coronavirus killer - Scope

The novel coronavirus – SARS-CoV-2 – may have been in Europe for longer than previously thoughtThe novel coronavirus – SARS-CoV-2 – may have been in Europe for longer than previously thought

Was Coronavirus Really in Europe in March 2019?

Most antivirals in use today target parts of an invading virus itself. Unfortunately, SARS-CoV-2—the virus that causes COVID-19—has proven hard to kill. But viruses rely on cellular mechanisms in human cells to help them spread, so it should be possible to change an aspect of a person's body to prevent that and slow down the virus enough to allow the immune system to fight the invader off.Most antivirals in use today target parts of an invading virus itself. Unfortunately, SARS-CoV-2—the virus that causes COVID-19—has proven hard to kill. But viruses rely on cellular mechanisms in ...

Coronavirus and cancer hijack the same parts in human cells to spread: Existing cancer drugs could fight COVID-19

More than 300 scientists and clinicians from the federal government, industry and academia published a report of their conclusions and recommendations on COVID-19 serology studies online in Immunity. The group gathered for an online workshop in May to discuss the role of serology testing in understa

Experts Identify Steps to Expand and Improve Antibody Tests in COVID-19 Response

Experts Identify Steps to Expand and Improve Antibody Tests in COVID-19 Response – SciTechDaily

They said sometimes this hijacking interferes with the activity of the host's proteins and other important molecules such as enzymes, which change protein activity by making chemical modifications to its structure.They said sometimes this hijacking interferes with the activity of the host's proteins and other important molecules such as enzymes, which change protein activity by making chemical modifications to its structure.

Scientists identify drugs that may block coronavirus from jumping to uninfected cells - The Economic Times

An international team of researchers has analyzed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins in its target cells. The research, published in the journal Cell, shows how the virus ...

Existing drugs can prevent SARS-CoV-2 from hijacking cells

Scientists have started to analyze a mutation of the coronavirus that some believe has the potential to make the virus more contagious, according to a report.Scientists have started to analyze a mutation of the coronavirus that some believe has the potential to make the virus more contagious, according to a report.

From the dangers of an overactive immune response to how SARS-CoV-2 hijacks the host cells' proteins, ThePrint brings you the latest research on coronavirus.

Web-like substance emitted by white blood cells could worsen outcome in Covid patients: Study

From the dangers of an overactive immune response to how SARS-CoV-2 hijacks the host cells' proteins, ThePrint brings you the latest research on coronavirus.

Web-like substance emitted by white blood cells could worsen outcome in Covid patients: Study

The researchers note that these findings are in line with a recent study, published in Cell, that showed a robust T cell response in individuals with moderate cases of Covid-19.The researchers note that these findings are in line with a recent study, published in Cell, that showed a robust T cell response in individuals with moderate cases of Covid-19.

New Research: Lessons from immune response of most severe Covid patients | Explained News,The Indian Express

You have been blocked

 The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19, the illness caused by the virus. "Tentacles" on hijacked cells might help coronavirus spread The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19, the illness caused by the virus.

Tentacles on cells may help coronavirus spread to other cells; risk not significantly higher in people with HIV | Deccan Herald

2 promising therapies among weapons dispatched against coronavirus 2 promising therapies among weapons dispatched against coronavirus

COVID-19: Plasma therapy vs stem cell therapy, what’s the difference? | Uae – Gulf News

As scientists and researchers work to provide everyone with information about the new coronavirus as quickly as possible, they have to be sure the data is helpful and accurate. That daunting task is being... Science News Summaries. | NewserChange involves spike proteins, researchers say

Mutation May Be Increasing Coronavirus' Infectiousness

Access Denied

 

GROWING OLD UNGRACEFULLY: All Creatures Great and Small | Lost Coast Outpost | Humboldt County News

New electron microscope images released in a study from a team of researchers led by scientists at the University of California, San Francisco appear to show cells infected with COVID-19 growing arm-like tentacles to infect other cells. New electron microscope images released in a study from a team of researchers led by scientists at the University of California, San Francisco appear to show cells infected with COVID-19 growing arm-like tentacles to infect other cells. 

When a virus infects a cell, it hijacks enzymes called kinases that control the cell's functions.When a virus infects a cell, it hijacks enzymes called kinases that control the cell's functions.

Tentacles on cells may help virus spread to other cells; risk not significantly higher in people with HIV

In the study, published on Sunday in the journal Cell, the scientists analysed all host and viral proteins that showed changes in an enzymatic process called phosphorylation after SARS-CoV-2 infection. In the study, published on Sunday in the journal Cell, the scientists analysed all host and viral proteins that showed changes in an enzymatic process called phosphorylation after SARS-CoV-2 infection.

Scientists Identifies Drugs that May Block Coronavirus from Jumping to Uninfected Cells

Kinases are cellular control switches. When they malfunction, they can cause cancer. The coronavirus hijacks these kinases to replicate, and cancer drugs that target them could fight COVID-19.Kinases are cellular control switches. When they malfunction, they can cause cancer. The coronavirus hijacks these kinases to replicate, and cancer drugs that target them could fight COVID-19.

Coronavirus and cancer hijack the same parts in human cells to spread – and our team identified existing cancer drugs that could fight COVID-19

Coronavirus and cancer hijack the same parts in human cells to spread – and our team identified existing cancer drugs that could fight COVID-19

Most antivirals in use today target parts of an invading virus itself. Unfortunately, SARS-CoV-2 – the virus that causes COVID-19 – has proven hard to kill. But viruses rely on cellular mechanisms in human cells to help them spread, so it should be possible to change an aspect of a person’s body to prevent that […]

Coronavirus and cancer hijack the same parts in human cells to spread – and some cancer drugs could fight COVID-19 – Raw Story

More than half a million people have died from Covid-19 globally. It is a major tragedy, but perhaps not on the scale … Continue reading "Is coronavirus burning out after 20% of a population is infected?"

Is coronavirus burning out after 20% of a population is infected? - Reaction

The novel coronavirus – SARS-CoV-2 – may have been in Europe for longer than previously thought. Recent studies have suggested that it was circulating in Italy as early as December 2019. More surprisingly, researchers at the University of BarceThe novel coronavirus – SARS-CoV-2 – may have been in Europe for longer than previously thought. Recent studies have suggested that it was circulating in Italy as early as December 2019. More surprisingly, researchers at the University of Barcelo

Study Found Traces of Coronavirus in Europe in March 2019. Here's What That Means